{"title": "Drugs.com - Prescription Drug Information", "author": null, "url": "https://www.drugs.com/", "hostname": "drugs.com", "description": "Providing accurate, impartial information on more than 24,000 prescription drugs and OTC medications.", "sitename": "Drugs.com", "date": "2023-09-06", "cleaned_text": "popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. [Traumatic Brain Injury Linked to Cognitive Decline in Twin Study](/news/traumatic-brain-injury-linked-cognitive-decline-twin-study-114858.html) Traumatic brain injury (TBI) is associated with cognitive decline later in life, according to a study published online Sept. 6 in Neurology. Marianne Chanti-Ketterl,... [Atezolizumab Can Induce Response in Alveolar Soft Part Sarcoma](/news/atezolizumab-can-induce-response-alveolar-soft-part-sarcoma-114855.html) The immunotherapy agent atezolizumab induces sustained responses in about one-third of patients with advanced alveolar soft part sarcoma (ASPS), according... [Panel of 48 CSF Proteins Complements Existing Alzheimer Biomarkers](/news/panel-48-csf-proteins-complements-existing-alzheimer-biomarkers-114856.html) A panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published... [Hepatitis C Virus Still Leading Cause of Hepatocellular Cancer in Men](/news/hepatitis-c-virus-still-leading-cause-hepatocellular-cancer-men-114857.html) The leading cause of hepatocellular carcinoma (HCC) is still hepatitis C virus (HCV) among men, but the rates of HCV-HCC have decreased since 2015, according... [Bryostatin-1 Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study](/clinical_trials/bryostatin-1-shows-statistically-significant-results-als-pre-clinical-independent-study-21011.html) NEW YORK, Sept. 7, 2023. Synaptogenix, Inc. (\"Synaptogenix\" or the \"Company\"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative... [Anti-Vax Trend May Harm Pet Dogs, With Half of Owners Against Immunization](/news/anti-vax-trend-may-harm-pet-dogs-owners-against-immunization-114852.html) Some people mistrust the safety and effectiveness of human vaccines for COVID-19 and other diseases, a fact that became abundantly clear during the pandemic. Now,... [Survey Shows American Men Less Healthy Than They Believe](/news/survey-shows-american-men-less-healthy-than-they-believe-114853.html) Most American men think they're leading a healthy lifestyle, possibly picturing themselves as a Hollywood leading man type. But their actual health... [In Small Study, Ozempic Helped People With Type 1 Diabetes Quit Insulin Treatments](/news/small-study-ozempic-helped-type-1-diabetes-quit-insulin-treatments-114845.html) The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The... [In a First, Scientists Grow Human Kidneys Inside Pigs](/news/first-scientists-grow-human-kidneys-inside-pigs-114838.html) For the first time ever, a solid humanized organ has been grown from scratch in an animal \u2014 a first step in a process that could potentially solve... [Janssen Announces Update to Phase 3 MACiTEPH Study Evaluating Macitentan 75mg in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH)](/clinical_trials/janssen-announces-update-phase-3-maciteph-study-evaluating-macitentan-75mg-patients-chronic-21013.html) RARITAN, NJ, September 6, 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced its decision to stop the Phase 3 MACiTEPH... [New COVID Variant May Be Less Threatening Than First Feared](/news/new-covid-variant-may-less-threatening-than-first-feared-114780.html) TUESDAY, Sept. 5, 2023 - When new COVID variant BA.2.86 emerged in late July, scientists had concerns about its ability to evade immunity. But early... [WEFUN Inc. Issues Voluntary Nationwide Recall of WEFUN Capsules Due to Presence of Undeclared Sildenafil](/fda/wefun-inc-issues-voluntary-nationwide-recall-wefun-capsules-due-presence-undeclared-sildenafil-14607.html) Brooklyn, New York, WEFUN Inc. is voluntarily recalling 300 Boxes of WEFUN Capsules to the consumer level. FDA analysis has found the product to be tainted... [X4 Pharmaceuticals Announces Submission of New Drug Application (NDA) to U.S. FDA for Mavorixafor in WHIM Syndrome](/nda/mavorixafor_230905.html) X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced the submission... [FDA Accepts Application for Genentech's Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition](/nda/crovalimab_230904.html) September 4, 2023 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA)... [Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma](/clinical_trials/coherus-announces-positive-final-overall-survival-results-jupiter-02-phase-3-trial-evaluating-20846.html) Coherus BioSciences, Inc. (\"Coherus\", Nasdaq: CHRS) announced the final overall survival (OS) results of the JUPITER-02 study presented today... Recently Added Recently added Latest FDA New Drug Approvals - [Tyruko](/tyruko.html)Tyruko (natalizumab-sztn) is an integrin receptor antagonist biosimilar to Tysabri, approved for the treatment of multiple sclerosis and... - [Eylea HD](/eylea.html)Eylea HD (aflibercept) is a higher dose formulation of the approved vascular endothelial growth factor (VEGF) a complement C5 inhibitor indicated for the treatment of adult and pediatric patients 1 year of age and older... Drugs in Development (Not yet approved) [Yutrepia](/history/yutrepia.html)Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to... [Libervant](/history/libervant.html)Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters. "}